Position history for Capital International Investors's holdings in ABBOTT LABORATORIES
Capital International Investors holds 37.5M shares of ABT (ABBOTT LABORATORIES), worth $3.8B as of 2026-Q1. The position was decreased (-40.7% shares). ABT represents 0.9% of Capital International Investors's portfolio.
Current Value
$3.8B
Current Shares
37.5M
Total Value Change
-$3.6B
Total Shares Change
-34.3M
Other major holders of ABT: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Decreased |
| 37.5M |
-40.7% |
| $3.8B |
| 0.9% |
| $113.61 |
0 |
| 2025-Q4 | Increased | 63.2M | +2.6% | $7.9B | 1.2% | $125.15 | 52 |
| 2025-Q3 | Increased | 61.6M | +2.5% | $8.3B | 1.3% | $131.85 | 51 |
| 2025-Q2 | Decreased | 60.1M | -10.0% | $8.2B | 1.4% | $132.52 | 0 |
| 2025-Q1 | Decreased | 66.8M | -1.7% | $8.9B | 1.7% | $128.41 | 0 |
| 2024-Q4 | Increased | 68M | +3.4% | $7.7B | 1.4% | $110.14 | 52 |
| 2024-Q3 | Decreased | 65.7M | -8.4% | $7.5B | 1.4% | $109.27 | 0 |
| 2024-Q2 | Increased | 71.8M | +2.3% | $7.5B | 1.5% | $100.45 | 51 |